Financial Year |
March 31 2023 |
Monetary Funds |
11,162,616,801.72 |
Held-for-trading Financial Assets |
595,505,655.37 |
Notes Receivable |
607,016,815.09 |
Accounts Receivable |
3,829,014,891.07 |
Advances to Suppliers |
1,459,820,345.08 |
Other Receivables |
67,402,132.49 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,919,057,256.26 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
813,082,360.19 |
Other Current Assets |
287,157,639.21 |
Total Current Assets |
22,169,751,640.13 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
279,594,728.20 |
Long-term Equity Investment |
240,005,584.52 |
Investment Properties |
-- |
Fixed Assetes |
2,022,839,292.92 |
Under-construction Projects |
1,006,946,990.43 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
167,193,640.17 |
R&D expenses |
-- |
Goodwill |
51,411,704.37 |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
417,230,325.78 |
Other Non-Current Assets |
119,608,134.80 |
Sub-Total of Non-Current Assets |
4,476,409,456.59 |
Total Assets |
26,646,161,096.72 |
Short-Term Loans |
2,352,314,067.98 |
Trading Financial liabilities |
-- |
Notes Payable |
1,543,639,223.53 |
Accounts Payable |
5,339,695,059.26 |
Accounts Received In Advance |
35,962,250.75 |
Employee Compensation Payable |
214,457,825.31 |
Taxes Payable |
186,265,722.18 |
Interest Payable |
-- |
Dividend Payable |
29,829,799.84 |
Other payables |
398,789,844.55 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
233,387,450.68 |
Other Current Liabilities |
550,377,933.43 |
Sub-Total of Current Liabilities |
15,311,608,918.91 |
Long-term Loans |
1,842,975,070.96 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
202,015,160.00 |
Special Payable |
-- |
Estimatied Liabilities |
11,262,466.45 |
Deferred Income Tax Liabilities |
39,173,171.87 |
Other Non-Current Liabilities |
121,962,433.86 |
Sub-Total of Non-Current Liabilities |
2,357,936,801.92 |
Total Liabilities |
17,669,545,720.83 |
Paid-In Capital(Or Share Stock) |
1,727,594,779.00 |
Capital Surplus |
2,477,437,539.05 |
Surplus Reserve |
1,295,342,393.36 |
LESS:Treasury Stock |
230,613,500.00 |
Undistributed Profits |
2,996,106,761.19 |
Minority Stockholder's Interest |
524,485,261.12 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,452,130,114.77 |
Owner's Equity(Stockholder's Equity) |
8,976,615,375.89 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
26,646,161,096.72 |